5-Fluorouracil as chemoadjuvant for primary pterygium surgery: Preliminary report

Cornea

Volumn 22, Issue 6, 2003, Pages 522-526

  Akarsu, Cengiz ^a   Taner, Pelin ^b   Ergin, Ahmet ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b NONE

Author keywords

5 fluorouracil; Final appearance; Pterygium; Recurrence

Indexed keywords

CYCLOPLEGIC AGENT; FLUOROMETHOLONE; FLUOROURACIL; GENTAGUT; GENTAMICIN; SIKLOPLEJIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CORNEA; DRUG EFFICACY; DRUG SAFETY; EYE IRRITATION; EYE SURGERY; FEMALE; HUMAN; HYPEREMIA; KERATITIS; MALE; PAIN; PHOTOPHOBIA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PTERYGIUM;

ADULT; CONJUNCTIVA; FEMALE; FLUOROURACIL; HUMANS; INJECTIONS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NUCLEIC ACID SYNTHESIS INHIBITORS; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE CARE; PTERYGIUM; RECURRENCE;

EID: 0041342968     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200308000-00007     Document Type: Article

References (51)

1. Singh G, Wilson MR, Foster CS. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988;95:813-821.
2. Sebban A, Hirst LW. Pterygium recurrence rate at the Princess Alexandra Hospital. Aust N Z J Ophthalmol. 1991;19:203-206.
3. Chen PP, Ariyasu RG, Kaza V, et al. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol. 1995;120:151-160.
4. Lam DS, Wong AK, Fan DS, et al. Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology. 1998;105:901-904.
5. Kleis W, Pico G, Thio-tepa therapy to prevent postoperative pterygium occurrence and neovascularization. Am J Ophthalmol. 1973;76:371-373.
6. Bahrassa F, Datta R. Postoperative beta radiation treatment of pterygium. Int J Radiat Oncol Biol Phys. 1983;9:679-684.
7. Simsek T, Gunalp I, Atilla H. Comparative efficacy of beta-irradiation and mitomycin-C in primary and recurrent pterygium. Eur J Ophthamol. 2001;11:126-132.
8. Apaydin KC, Duranoglu Y, Saka O, et al. Argon laser treatment of pterygium. Ann Ophthamol. 2002;34:26-29.
9. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92:1461-1470.
10. Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology. 1989;96:1612-1614.
11. Mutlu FM, Sobaci G, Tatar T, et al. A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology. 1999;106:817-821.
12. Sharma A, Gupta A, Ram J, et al. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000;31:301-307.
13. McCoombes JA, Hirst LW, Isbell GP. Sliding conjunctival flap for the treatment of primary pterygium. Ophthamology. 1994;101:169-173.
14. Solomon A, Pires RT. Tseng SC. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001;108:449-460.
15. Talu H, Tasindi E, Ciftci F, et al. Excimer laser phototherapeutic keratectomy for recurrent pterygium. J Cataract Refract Surg. 1998;24:1326-1332.
16. Hayasaka S, Noda S, Yamamoto Y, et al. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988;106:715-718.
17. Frucht-Pery J, Ilsar M, Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium-preliminary report. Cornea. 1994;13:411-413.
18. Cano-Parra J, Diaz-Llopis M, Maldonado MJ, et al. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol. 1995;79:439-441.
19. Heiligenhaus A, Akova Y, Lung E, et al. Pterygium excision with intra-operative administration of low dosage mitomycin C. Ophthalmologe. 1995;92:458-462.
20. Cardillo JA, Alves MR, Ambrosio LE, et al. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Ophthalmology. 1995;102:1949-1952.
21. Caliskan S, Orhan M, Irkec M. Intraoperative and postoperative use of mitomycin-C in the treatment of primary pterygium. Ophthalmic Surg Lasers. 1996;27:600-604.
22. Rubinfeld RS, Stein RM. Topical mitomycin-C for pterygia: is single application appropriate? Ophthalmic Surg Lasers. 1997;28:662-669.
23. Manning CA, Kloess PM, Diaz MD, et al. Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial. Ophthalmology. 1997;104:844-848.
24. Oguz H, Basar E, Gurler B. Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand. 1999;77:147-150.
25. Demirok A, Simsek S, Cinal A, et al. Intraoperative application of mitomycin C in the surgical treatment of pterygium. Eur J Ophthalmol 1998;8:153-156.
26. Yanyali AC, Talu H, Alp BN, et al. Intraoperative mitomycin C in the treatment of pterygium. Cornea. 2000;19:471-473.
27. Hill JC, Maske R. Pathogenesis of pterygium. Eye. 1989;3:218-226.
28. Fisher JF, Aristoff PA. The chemistry of DNA modification by antitumor antibiotics. Prog Drug Res. 1988;32:411-498.
29. Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol. 1991:112:343-344.
30. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647-1654.
31. Gupta S, Basti S. Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C. Am J Ophthalmol. 1992;114:503-504.
32. Fujitani A, Hayasaka S, Shibuya Y, et al. Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica. 1993;207:162-164.
33. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea. 1996;15:537-540.
34. Maldonado MJ, Cano-Parra J, Navea-Tejerina A, et al. Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium. Arch Ophthalmol. 1995:113:1356-1357.
35. Evans RM, Laskin JD, Hakala MT. Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells and in human cells. Cancer Res. 1980;40:4113-4122.
36. Troutbeck R, Hirst L. Review of treatment of pterygium in Queensland: 10 years after a primary survey. Clin Exp Ophthalmol. 2001;29:286-290.
37. Haik GM. The management of pterygia. A third report on a combined surgical-irradiation technique. Am J Ophthalmol. 1966;61:1128-34.
38. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol. 1980;64:496-505.
39. Moriarty AP, Crawford GJ, McAllister IL, et al. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol. 1993;111:947-951.
40. Starck T, Kenyon KR, Serrano F. Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management. Cornea. 1991;10:196-202.
41. Sridhar MS, Bansal AK, Rao GN. Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft. Cornea. 2002;21:305-307.
42. Al Fayez MF. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 2002;109:1752-1755.
43. Starc S, Knorr M, Steuhl KP, et al. Autologous conjunctiva-limbus transplantation in treatment of primary and recurrent pterygium. Ophthalmologe. 1996;93:219-223.
44. Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology. 1987;94:564-570.
45. Khaw PT, Doyle JW, Sherwood MB, et al. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol. 1993;111:263-267.
46. Morrow GL, Stein RM, Heathcote JG, et al. Ocular toxicity of mitomycin C and 5-fluorouracil in the rabbit. Can J Ophthalmol. 1994;29:268-273.
47. Pikkel J, Porges Y, Ophir A. Halting pterygium recurrence by postoperative 5-fluorouracil. Cornea. 2001;20:168-171.
48. Hirst LW, Sebban A, Chant D. Pterygium recurrence time. Ophthalmology. 1994;101:755-758.
49. Cunliffe IA, Longstaff S. Intra-operative use of 5- fluorouracil in glaucoma filtering surgery. Acta Ophthalmol. 1993;71:739-743.
50. Detry-Morel M, Kolanowski C. Use of 'low dose' 5-fluorouracil during trabeculectomy. Bull Soc Belge Ophtalmol. 1999;272:33-42.
51. Merriman MB, Mora JS, Beaumont BW, et al. Effects of varying 5-fluorouracil exposure duration on tenon's capsule fibroblasts. Clin Exp Ophthalmol. 2001;29:248-252.